Instil Bio (TIL) Current Assets (2020 - 2026)

Instil Bio has reported Current Assets for 7 years, with the latest figure at $71.6 million in Q2 2026.

• On a quarterly basis, Current Assets fell 65.47% year-over-year to $71.6 million in Q2 2026; TTM through Jun 2026 was $71.6 million, a 65.47% decrease from a year earlier, with the FY2025 full-year figure at $191.4 million, up 53.8% from the prior year.
• Current Assets was $71.6 million for Q2 2026 at Instil Bio, down from $188.3 million in the prior quarter.
• The five-year high for Current Assets was $390.7 million in Q1 2022, with the low at $71.6 million in Q2 2026.
• Average Current Assets over 5 years is $211.4 million, with a median of $195.9 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Current Assets surged 53.8% in 2025, then sank 65.47% in 2026.
• Over 5 years, Current Assets stood at $269.4 million in 2022, then slumped by 40.32% to $160.8 million in 2023, then retreated by 22.57% to $124.5 million in 2024, then soared by 53.8% to $191.4 million in 2025, then sank by 62.59% to $71.6 million in 2026.
• The last three Current Assets figures came in at $71.6 million (Q2 2026), $188.3 million (Q1 2026), and $191.4 million (Q4 2025), per Business Quant data.